Central Pharmaceutical Joint Stock Company No3 (HNX:DP3)
Vietnam · Delayed Price · Currency is VND 52,700
+200 (0.38%)
At close: Aug 4, 2025
HNX:DP3 Revenue
Central Pharmaceutical Joint Stock Company No3 had revenue of 94.24B VND in the quarter ending June 30, 2025, a decrease of -7.99%. This brings the company's revenue in the last twelve months to 397.55B, up 0.59% year-over-year. In the year 2024, Central Pharmaceutical Joint Stock Company No3 had annual revenue of 417.49B with 1.89% growth.
Revenue (ttm)
397.55B
Revenue Growth
+0.59%
P/S Ratio
2.82
Revenue / Employee
n/a
Employees
n/a
Market Cap
1,122.30B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 417.49B | 7.75B | 1.89% |
| Jan 1, 2024 | 409.73B | -75.34B | -15.53% |
| Dec 31, 2022 | 485.07B | 104.00B | 27.29% |
| Dec 31, 2021 | 381.08B | -14.64B | -3.70% |
| Dec 31, 2020 | 395.72B | -15.71B | -3.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition